Disclosures for "Clinical Management of Rett Syndrome in the Real World: A Physician Survey")
-
Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group. Dr. Neul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alcyone. Dr. Neul has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid. Dr. Neul has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Neul has stock in LizardBio. The institution of Dr. Neul has received research support from NIH. The institution of Dr. Neul has received research support from Acadia. The institution of Dr. Neul has received research support from GW Pharmaceuticals. The institution of Dr. Neul has received research support from International Rett Syndrome Foundation. The institution of Dr. Neul has received research support from Rett Syndrome Research Trust.
-
Dr. May has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. May has stock in ACADIA Pharmaceuticals. Dr. May has stock in Medtronic. Dr. May has stock in Johnson & Johnson. Dr. May has stock in Pfizer Pharmaceuticals.
-
Dr. Satija has received personal compensation for serving as an employee of Analysis Group, Inc.. The institution of Dr. Satija has received research support from Acadia Pharmaceuticals.
-
Wendy Cheng, 15773 has received personal compensation for serving as an employee of Analysis Group, Inc..
-
Miss Lema has received personal compensation for serving as an employee of Analysis Group, Inc..
-
Miss Boca has received personal compensation for serving as an employee of Analysis Group, Inc.. The institution of Miss Boca has received research support from Acadia Pharmaceuticals Inc.
-
The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Acadia Pharmaceuticals. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for GSK. The institution of Patrick Lefebvre has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Janssen Scientific Affairs. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Novartis. The institution of Patrick Lefebvre has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Otsuka. The institution of Patrick Lefebvre has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Pharmacyclics. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pfizer. The institution of Patrick Lefebvre has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Regeneron.
-
Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received publishing royalties from a publication relating to health care.